Louisiana Hemp THC Market Faces Federal Hemp Ban Challenges
Louisiana hemp THC products face uncertainty as the federal hemp THC ban approaches in 2026. This ban impacts the availability and regulation of hemp THC drinks in Louisiana. Consumers and patients should understand the implications for access and…
CED Cannabis News Digest: Enforcement and Licensing Updates
This cannabis news digest covers new york illicit cannabis enforcement efforts, d.c.'s medical cannabis licensing denial, and thailand's prescription-only cannabis flower reminder. These stories highlight key regulatory changes shaping legal cannabis…
North Carolina Hemp THC Bill Clears Senate but Stalls in House: What the Split Means for Patients
The North Carolina hemp THC bill recently cleared the Senate but stalled in the House, creating uncertainty for patient access. This legislation aims to regulate intoxicating hemp products with age restrictions and safety rules. CED Clinic explains the…
Kentucky Medical Cannabis Purchase Limits and Access Update
Kentucky medical cannabis purchase limits changed in July 2026, ending protections for out-of-state cardholder purchases. This update impacts patient access and dispensary options statewide. The change reflects a shift toward tighter intrastate control…
Georgia Expands Medical Cannabis Access: New Pharmacy and Product Rules Explained
Georgia medical cannabis pharmacy distribution expanded in 2026, improving patient access and product variety. The new rules allow vaporized flower and stronger products. CED Clinic explains what these changes mean for patients and clinicians.
Louisiana Sees Further Medical Cannabis Dispensary Expansion with New NOLA … – Hemp Gazette
✦ New CED Clinical Relevance #60 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyIndustryHempCBDTHCMedical CannabisDispensary Clinical Summary Louisiana’s expansion of medical cannabis…
Why the future of marijuana legalization remains hazy despite high public support
Cannabis legalization implementation challenges continue to create barriers between public support and actual patient access to medical cannabis. Complex regulatory frameworks and federal-state conflicts complicate clinical decision-making and treatment…
Does Kaiser cover CBD gummies?
Kaiser Permanente typically does not cover CBD gummies due to federal restrictions and FDA approval requirements. Understanding kaiser permanente cbd gummy coverage helps patients budget appropriately for cannabis therapeutics. Dr. Caplan explains…
Death of Medical Cannabis Patient Highlights Ongoing Stigma in Organ Transplant Programmes
Medical cannabis organ transplant discrimination policies continue to deny life-saving care based on outdated stigma rather than clinical evidence. Transplant centers must reconcile legitimate medical cannabis therapy with evidence-based transplant…
Texas Rescinds Cresco Labs’ Awarded License for Medical Cannabis Market
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustry Why This Matters License rescissions directly affect patient access to medical cannabis products and the…